The authors reply

New England Journal of Medicine

Volumn 373, Issue 3, 2015, Pages 287-288

  Leffler, Daniel A ^a   Lamont, J Thomas ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTON PUMP INHIBITOR; ANTIINFECTIVE AGENT;

BACTERIAL STRAIN; CLOSTRIDIUM DIFFICILE INFECTION; COLON LAVAGE; COLON RESECTION; DISEASE ASSOCIATION; DRUG EFFECT; DRUG USE; HUMAN; ILEOSTOMY; INFECTION PREVENTION; INFECTION RISK; INTESTINE ANASTOMOSIS; INTESTINE INFECTION; LETTER; PEPTOCLOSTRIDIUM DIFFICILE; PRIORITY JOURNAL; RECURRENT INFECTION; RISK FACTOR; SURGICAL MORTALITY; SURVIVAL; TREATMENT OUTCOME; CLOSTRIDIUM INFECTION;

ANTI-BACTERIAL AGENTS; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; HUMANS;

EID: 84937028983     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1506004     Document Type: Letter

References (5)

1. Seto CT, Jeraldo P, Orenstein R., Chia N, DiBaise JK. Prolonged use of a proton pump inhibitor reduces microbial diversity: implications for Clostridium difficile susceptibility. Microbiome 2014; 2:42.
2. Novack L, Kogan S, Gimpelevich L., et al. Acid suppression therapy does not predispose to Clostridium difficile infection: the case of the potential bias. PLoS One 2014; 9(10):e110790.
3. Gerding DN, Meyer T, Lee C., et al. Administration of spores of nontoxigenic Clostridium difficile strain M3 for prevention of recurrent C. difficile infection: a randomized clinical trial. JAMA 2015; 313:1719-27.
4. Stewart DB, Hollenbeak CS, Wilson MZ Is colectomy for fulminant Clostridium difficile colitis life saving? A systematic review. Colorectal Dis 2013; 15:798-804.
5. Na X, Martin AJ, Sethi S, et al A multi-center prospective derivation and validation of a clinical prediction tool for severe Clostridium difficile infection. PLoS One 2015; 10(4):e0123405.